¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"integration host factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
host range
¼÷ÁÖ¹üÀ§
host selection
¼÷ÁÖ¼±ÅÃ
host specificity
¼÷ÁÖÆ¯À̼º
host susceptibility
¼÷ÁÖ°¨¼ö¼º
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
host-range mutant
¼÷ÁÖ¹üÀ§µ¹¿¬º¯ÀÌÁÖ
intermediate host
Áß°£¼÷ÁÖ
primary host
Á¾¼÷ÁÖ
paratenic host
¿¬Àå¼÷ÁÖ
reservoir host
º¸À¯¼÷ÁÖ
susceptible host
°¨¼ö¼º¼÷ÁÖ
unnatural host
ºñÈ£Àû¼÷ÁÖ
antihemophilic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
12
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
definitive host
ÃÖÁ¾¼÷ÁÖ
graft-versus-host disease
À̽Ĵë¼÷ÁÖº´
host defense
¼÷ÁÖ¹æ¾î
final host
(¢¡definitive host) ÃÖÁ¾¼÷ÁÖ
graft versus host reaction
ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
host
¼÷ÁÖ
host preference
¼÷ÁÖ¼±È£
host range
¼÷ÁÖ¹üÀ§
host selection
¼÷ÁÖ¼±ÅÃ
host specificity
¼÷ÁÖÆ¯À̼º
host susceptibility
¼÷ÁÖ°¨¼ö¼º
host range mutation
¼÷ÁÖ¹üÀ§º¯ÀÌ, ¼÷ÁÖ¿ªº¯ÀÌ
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
host-parasite relationship
¼÷ÁÖ±â»ýü»óÈ£°ü°è
host-parasite specificity
¼÷ÁÖ±â»ýÃæÆ¯À̼º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
AHF=£¾antihemophilic factor
Ç×Ç÷¿ìÀÎÀÚ.
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
Castles extrinsic factor
Ĺ½½¿ÜÀÎÀÚ.
Castles intrinsic factor
Ĺ½½³»ÀÎÀÚ.
Christmas factor
Å©¸®½º¸¶½º ÀÎÀÚ(ì×í)
Christmas factor.
Å©¸®½º¸¶½ºÀÎÀÚ
D factor
DÀÎÀÚ
Decay accelerating factor
ºØ±«°¡¼Ó¿ä¼Ò(¿äÀÎ)
EDCF (endothlium-derived contracting factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ¼öÃàÀÎÀÚ(â¥õêì×í)
EDRF (endothlium-derived relaxing factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ÀÌ¿ÏÀÎÀÚ(ì¬èÐì×í)
EDRF=£¾endothelium derived relaxing factor
³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ.
F factor
FÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
graft versus host disease
ÀÌ½ÄÆí´ë¼÷ÁÖº´.
graft versus host disease
´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
graft versus host reaction
ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ(ì¹ãÕø¸ÓßâÖñ«Úãëë).
graft versus host reaction (GVHR)
´ë¼÷ÁÖÀÌ½ÄÆí¹ÝÀÀ
graft-versus-host disease
ÀÌ½ÄÆí´ë¼÷ÁÖº´
graft-versus-host disease
ÀÌ½ÄÆí´ë ¼÷ÁÖº´
host
¼÷ÁÖ
host
¼÷ÁÖ
host adaptation
¼÷ÁÖÀûÀÀ.
host attribute
¼÷ÁÖ¼Ó¼º.
host computer
ÁÖ ÄÄÇ»ÅÍ
host controlled variation
¼÷ÁÖÀÇÁ¸(±ÔÁ¦)º¯ÀÌ.
host defense
¼÷ÁÖ¹æ¾î
host range
¼÷ÁÖ¹üÀ§, ¼÷ÁÖ¿ª
host range mutation
¼÷ÁÖ¿ªº¯ÀÌ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½